BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 2, 2015
View Archived Issues
Bristol-Myers Squibb updates activities of fourth quarter 2014
Read More
Nanoliposomal irinotecan injection improves overall survival and objective response
Read More
Agios Pharmaceuticals discloses new inhibitors of mutant IDH2
Read More
Investigators in Japan patent novel P2X4 antagonists for pain
Read More
Biotie Therapies reports topline results from nepicastat study in cocaine dependence
Read More
New anti-IAPP MAbs disclosed by Neotope
Read More
Researchers prepare new synthetic vaccines for streptococcal infections
Read More
Roche reviews developments of fourth quarter 2014
Read More
Prezcobix approved in the U.S. for the treatment of adults with HIV-1
Read More
Astellas and Immunomic Therapeutics enter into agreement for JRC2-LAMP-vax
Read More
Valeant enters agreement to acquire Dendreon assets
Read More
Enrollment in phase IIb study of Ovasave for refractory Crohn's disease triggers payment to TxCell
Read More
Nuvo Research reports topline results of phase II WF-10 trial in allergic rhinitis
Read More
AstraZeneca, MD Anderson enter into collaboration for ovarian/gynecologic cancers
Read More
MicroConstants China in-licenses global rights to AA98 antibody-drug candidates
Read More
Sumitomo Dainippon Pharma reviews activities of third quarter of fiscal 2014
Read More
OPKO Health submits IND to begin phase IIa study of Factor VIIa-CTP
Read More
FDA approves Vyvanse for binge eating disorder
Read More
Xiapex approved in E.U. for Peyronie's disease
Read More
FDA approves first drug for Waldenstrom's macroglobulinemia
Read More
Pluristem releases further results from phase I/II trial of PLX-PAD in surgical muscle injury
Read More
Xencor reports results of study on XmAb-7195 in healthy volunteers
Read More
Breakthrough therapy designation granted Genentech's MPDL-3280A
Read More
Xencor releases topline phase Ib/IIa data for XmAb-5871
Read More
Management diagnostics receive two FDA orphan drug status
Read More